Passage Bio Inc (PASG) Opciones

make or break

Wedbush pump losing steam
the dilemma is the readouts are right around the corner

Next week should be interesting….will Pasg hold its gains or tank…was it a pump and dump day…..15 million share volume today …..massive increase …..hmmmmm

EVERYTHING the analyst said today was well known.
Direct CNS delivery... AAV gene therapy pioneer thinks AAV gene therapy will work in FTD too.... First one of its kind in FTD.... Then in recent months we got about a million validations of that ---------- No one bit this? They didnt believe him? Because he left again for head of gene therapy at PENNs and then went on to found 2 new companies instead of linger around at PASG at 60 something years?
No one believed he gave the steering wheel to Mr Chou because Wilson thought Chou could finish the job?

Analyst says most basic stuff and they go crazy?

will it keep going?

big pop coming. Science hated for no reason. Founder is gene therapy authority. AAV tech works.

PASG 10Q due AUGUST5

See the first rally on this after the big bar on the first data release. They saw something and took a seat. A lot of shares were bought. Thats because the platform works and will -- veeery surprisingly -- produce great data.

this is not a daytrade. I am invested here, waiting for the crowd/data.
I think a deal is coming on data release.... its a neglected approach. Founder is a genius and gene therapy authority, popularized AAVs. All the recent bio winners use them.
Happy trading

Ahem..

Going to explode on the next readout

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations

There are close to 1,000 listed med tech companies
Only so many can garner serious institutional interest

I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG

The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."

"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."

PASG under $2

PASG under $2

Running... boom!!!

PASG under $2

PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

PASG new 52 week high

PASG setting up nicely. Another beautiful call by the only true chartist around

Yup yup yup...

PASG...NEXT CRDL

PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783

PASG under $2

As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }

Data readout should be incoming shortly

PASG new 52 week low

So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.

PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.